NextBio Announces First Three Recipients of Student Travel Grants
* Reuters is not responsible for the content in this press release.
Winning Essays Convey How NextBio Helped Them Find Correlations, Make Discoveries Between their Research and Published Data CUPERTINO, Calif.--(Business Wire)-- NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced the inaugural recipients of the company`s NextBio Travel Grant. Each of the winners will receive $500 to support their travel to scientific conferences. The NextBio Travel Grant program was designed to encourage and support graduate student attendance at conferences, where they are exposed to new ideas, research strategies and potential collaborators just as NextBio itself supports knowledge discovery and collaboration. "We are very pleased to make the first three awards in this ongoing grant program," said Saeid Akhtari, NextBio President and Chief Executive Officer. "Our judges were very impressed with the quality of the entries and how clearly they articulated the value that NextBio delivers in its ability to rapidly uncover knowledge buried in the enormous wealth of publicly available and proprietary data." The first three NextBio Travel Grant recipients are: * Bryan Dickinson, graduate student in chemistry at the University of California Berkeley, Berkeley, California USA * Laura Mariani, graduate student in neuroscience at Emory University, Atlanta Georgia USA; and * Khader Shameer, senior research fellowin computational biology at the National Centre for Biological Sciences, Bangalore India To read the winning essays, find out more about the winners, and learn more about the NextBio Travel Grant program, please visit: http://www.nextbio.com/b/corp/grants.nb About NextBio NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio`s platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, providing the foundation for new scientific discoveries. NextBio helps organizations increase productivity and dramatically improve collaboration across therapeutic groups and geographic boundaries. NextBio is delivered as a SaaS (Software as a Service) solution resulting in quick deployment and rapid return on investment. Today, NextBio is used by over a million researchers at the world's top commercial and academic institutions. NextBio`s enterprise solution has been deployed at Burnham Institute for Medical Research, Celgene, Eli Lilly, Genzyme, Johnson & Johnson, Regeneron, Scripps Research Institute, Stanford University, and Takeda, among many others. To learn more about NextBio, please visit our website at http://www.nextbio.com. NextBio Andrew Grygiel, 408-861-3602 Vice President, Marketing andrew@nextbio.com or Kureczka/Martin Associates Joan Kureczka, 415-821-2413 Jkureczka@comcast.net Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters